These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 5092940)

  • 1. [Comparison of dose-dependent release of single monoamines from the rat brain by reserpine and oxypertine. Answer to the discussion contribution of M. Knaack and H. Quick to our paper on the different release of norepinephrine, dopamine and serotonin depots as a mode of oxypertine action this J. 41, 105 347 (1970)].
    Kim JS; Hassler R; Bak IJ
    Nervenarzt; 1971 Sep; 42(9):490-1. PubMed ID: 5092940
    [No Abstract]   [Full Text] [Related]  

  • 2. [Increase of cerebral dopamine levels by alpha-chymotrypsin in rats pretreated with oxypertine and L-dopa].
    Van den Driessche J; Le Clec'h G; Quiniou P; Linée P; Lacroix P; Patay M; Delamaire J
    C R Seances Soc Biol Fil; 1974; 168(10-11-12):1393-400. PubMed ID: 4157065
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of continuous administration for 12 months of amine-depleting drugs and chlorpromazine on striatal dopamine function in the rat.
    Hong M; Kilpatrick GJ; Jenner P; Marsden CD
    Neuropharmacology; 1987 Aug; 26(8):1061-9. PubMed ID: 2889161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of losulazine and reserpine on central aminergic neurons.
    Pan JT; Hooth MJ; Lookingland KJ; Moore KE; Marks TA
    Toxicol Appl Pharmacol; 1993 Nov; 123(1):26-33. PubMed ID: 8236258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the acute actions of amine-depleting drugs and dopamine receptor antagonists on dopamine function in the brain in rats.
    Hong M; Jenner P; Marsden CD
    Neuropharmacology; 1987; 26(2-3):237-45. PubMed ID: 2884588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic effects of oxypertine on the isolated vas deferens of the rat.
    Miranda H; Naquira D
    Gen Pharmacol; 1978; 9(5):325-8. PubMed ID: 29822
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
    Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
    Ann N Y Acad Sci; 2004 Oct; 1025():189-97. PubMed ID: 15542717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-sensitive liquid chromatographic method for determination of neuronal release of serotonin, noradrenaline and dopamine monitored by microdialysis in the rat prefrontal cortex.
    Yoshitake T; Yoshitake S; Fujino K; Nohta H; Yamaguchi M; Kehr J
    J Neurosci Methods; 2004 Dec; 140(1-2):163-8. PubMed ID: 15589346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of rats of pinealectomy and oxypertine on spontaneous locomotor activity and blood pressure during various light schedules.
    Karppanen H; Airaksinen MM; Särkimäki I
    Ann Med Exp Biol Fenn; 1973 Mar; 51(3):93-103. PubMed ID: 4774081
    [No Abstract]   [Full Text] [Related]  

  • 11. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake.
    Shaskan EG; Snyder SH
    J Pharmacol Exp Ther; 1970 Nov; 175(2):404-18. PubMed ID: 5481708
    [No Abstract]   [Full Text] [Related]  

  • 13. Peptide YY (3 -36) inhibits dopamine and norepinephrine release in the hypothalamus.
    Brunetti L; Orlando G; Ferrante C; Chiavaroli A; Vacca M
    Eur J Pharmacol; 2005 Sep; 519(1-2):48-51. PubMed ID: 16095590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of reserpine on monoamine uptake by rat brain synaptosomes].
    Blaschke M; Fischer HD; Rudolph E
    Acta Biol Med Ger; 1980; 39(11-12):1205-12. PubMed ID: 7245989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential depletion of storage sites for noradrenalin, dopamine and serotonin by oxypertin].
    Hassler R; Bak IJ; Kim JS
    Nervenarzt; 1970 Mar; 41(3):105-18. PubMed ID: 5447883
    [No Abstract]   [Full Text] [Related]  

  • 16. Actions at sites other than D(3) receptors mediate the effects of BP897 on l-DOPA-induced hyperactivity in monoamine-depleted rats.
    Visanji NP; Millan MJ; Brotchie JM
    Exp Neurol; 2006 Nov; 202(1):85-92. PubMed ID: 16814282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain.
    Assié MB; Ravailhe V; Faucillon V; Newman-Tancredi A
    J Pharmacol Exp Ther; 2005 Oct; 315(1):265-72. PubMed ID: 15987834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide 1 (7-36) amide (GLP-1) and exendin-4 stimulate serotonin release in rat hypothalamus.
    Brunetti L; Orlando G; Recinella L; Leone S; Ferrante C; Chiavaroli A; Lazzarin F; Vacca M
    Peptides; 2008 Aug; 29(8):1377-81. PubMed ID: 18502539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of reserpine on behavior and on brain concentrations of serotonin and norepinephrine in control rats and rats with hypothalamic lesions.
    Grabarits F; Harvey JA
    J Pharmacol Exp Ther; 1966 Sep; 153(3):401-11. PubMed ID: 5921526
    [No Abstract]   [Full Text] [Related]  

  • 20. A reassessment of the mechanism of reserpine-produced sedation.
    Millard SA; Gál EM
    Biol Psychiatry; 1969 Jul; 1(3):219-25. PubMed ID: 5352653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.